Citations 3

P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES

HemaSphere | May 11, 2023 | Volume: 7 | Issue: S2 | Pages: 41-42

10.1097/01.hs9.0000936352.84768.4d

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

JAMA | June 11, 2015 | Volume: 310 | Issue: 24 | Pages: 2658

10.1001/jama.2013.283815 | PMID 24368466

The Diflunisal Trial: Study accrual and drug tolerance

Amyloid | May 2, 2012 | Volume: 19 | Issue: sup1 | Pages: 37-38

10.3109/13506129.2012.678509 | PMID 22551208